[Turnover of central nervous system stimulating drugs in Norway during the period 1980-1989].
Statistics from the Norwegian Medicinal Depot (Norsk Medisinaldepot) show that sales of methylphenidate in Norway increased by approximately 300% from 1985 to 1989. The Norwegian Ministry of Health and Social Affairs (Directorate of Health) has approved only one indication for the use of stimulants in child and adolescent psychiatry, namely the hyperkinetic syndrome. The author discusses the explosive use of stimulant drugs and presents several interpretations. It is concluded that the indications for use of these drugs in child and adolescent psychiatry should be discussed and clarified.
Kayser
H G
HG
Barne- og ungdomspsykiatrisk poliklinikk, Fylkessjukehuset på Nordfjordeid.
D000661:Amphetamine / Q000008:administration & dosage; D002491:Central Nervous System Agents / Q000008:administration & dosage*; D004363:Drug Utilization; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage; D009664:Norway
D002491:Central Nervous System Agents; D008774:Methylphenidate; D000661:Amphetamine